Literature DB >> 30539489

Laterally Extended Pelvic Resection for Gynaecological Malignancies: A Multicentric Experience with Out-of-the-Box Surgery.

Giuseppe Vizzielli1, Raj Naik2, Lukas Dostalek3, Nicolò Bizzarri2, Ali Kucukmetin2, Giovanni Tinelli4, Giovanni Scambia5, David Cibula3.   

Abstract

PURPOSE: To evaluate morbidity and oncological outcome in a multicentre series of women with gynaecological malignancies infiltrating pelvic side wall (PSW) that received laterally extended pelvic resection (LEPR).
METHODS: Patients operated between 2007 and 2017 at three institutions were included. LEPR was defined as an en bloc lateral resection of a pelvic tumour involving sidewall muscle, and/or bone, and/or major nerve, and/or major vascular structure. Postsurgical complications and survivals were evaluated.
RESULTS: Sixty-three women with gynaecological tumours involving PSW were treated with LEPR. Five women underwent primary LEPR, whereas 58 (92%) patients needed LEPR because of recurrence. Twenty-four women (38%) received previous radiation therapy before the surgery. R0 resection was achieved in 54 patients (85.7%), whereas the pathologic margins were microscopically and macroscopically positive in 8 (12.7%) patients and 1 (1.6%) patient, respectively. There was one perioperative death, whereas major postoperative complications occurred in 17 patients (27.7%). Thirty (47.5%) women experienced recurrences: 24/54 (44.4%) were in the R0 group, and 6/9 (66.6%) were in the R1 group, with a median PFS of 15 months and 7 months, respectively (p = 0.024). In total, 11 of 54 (20.3%) patients died of disease in the R0 group and 5 of 9 (55.5%) in the R1 group; a median OS was not reached and was 32 months for R0 and R1 groups, respectively (p = 0.033).
CONCLUSIONS: Involvement of the PSW should not prevent obtaining R0 resection. Although the LEPR is associated with considerable morbidity (≈ 30%), a long-term survival seems to be achieved in those women with complete resection.

Entities:  

Mesh:

Year:  2018        PMID: 30539489     DOI: 10.1245/s10434-018-07088-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  Is a Vaginectomy Enough or is a Pelvic Exenteration Always Required for Surgical Treatment of Recurrent Cervical Cancer? A Propensity-Matched Study.

Authors:  Giuseppe Vizzielli; Lucia Tortorella; Carmine Conte; Vito Chiantera; Valerio Gallotta; Nazario Foschi; Martina Arcieri; Gabriella Ferrandina; Anna Fagotti; Filiberto Zattoni; Giovanni Scambia; Alfredo Ercoli
Journal:  Ann Surg Oncol       Date:  2020-10-15       Impact factor: 5.344

2.  ASO Authors Reflections: Vaginectomy as Surgical Treatment of Recurrent Cervical Cancer.

Authors:  Giuseppe Vizzielli; Vito Chiantera; Alfredo Ercoli; Giovanni Scambia
Journal:  Ann Surg Oncol       Date:  2020-10-24       Impact factor: 5.344

3.  Potential prognostic factors in progression-free survival for patients with cervical cancer.

Authors:  Hui-Hui Chen; Wei-Yu Meng; Run-Ze Li; Qing-Yi Wang; Yu-Wei Wang; Hu-Dan Pan; Pei-Yu Yan; Qi-Biao Wu; Liang Liu; Xiao-Jun Yao; Min Kang; Elaine Lai-Han Leung
Journal:  BMC Cancer       Date:  2021-05-10       Impact factor: 4.430

4.  Robotic Pelvic Exenteration for Gynecologic Malignancies, Anatomic Landmarks, and Surgical Steps: A Systematic Review.

Authors:  Stefano Cianci; Martina Arcieri; Giuseppe Vizzielli; Canio Martinelli; Roberta Granese; Marco La Verde; Anna Fagotti; Francesco Fanfani; Giovanni Scambia; Alfredo Ercoli
Journal:  Front Surg       Date:  2021-11-30

5.  Safety and feasibility of laterally extended endopelvic resection for sarcoma in the female genital tract: a prospective cohort study.

Authors:  Soo Jin Park; Junhwan Kim; Jae-Weon Kim; Hee Seung Kim; Ga Won Yim
Journal:  Obstet Gynecol Sci       Date:  2022-06-27

Review 6.  Recurrent Endometrial Cancer: Which Is the Best Treatment? Systematic Review of the Literature.

Authors:  Stefano Restaino; Giorgia Dinoi; Eleonora La Fera; Benedetta Gui; Serena Cappuccio; Maura Campitelli; Giuseppe Vizzielli; Giovanni Scambia; Francesco Fanfani
Journal:  Cancers (Basel)       Date:  2022-08-29       Impact factor: 6.575

7.  Laterally Extended Endopelvic Resection Versus Chemo or Targeted Therapy Alone for Pelvic Sidewall Recurrence of Cervical Cancer.

Authors:  Soo Jin Park; Jaehee Mun; Seungmee Lee; Yanlin Luo; Hyun Hoon Chung; Jae-Weon Kim; Noh Hyun Park; Yong Sang Song; Hee Seung Kim
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

8.  Indocyanine Green to Assess Vascularity of Ileal Conduit Anastomosis During Pelvic Exenteration for Recurrent/Persistent Gynecological Cancer: A Pilot Study.

Authors:  Nicolò Bizzarri; Nazario Foschi; Matteo Loverro; Lucia Tortorella; Francesco Santullo; Andrea Rosati; Salvatore Gueli Alletti; Barbara Costantini; Valerio Gallotta; Gabriella Ferrandina; Anna Fagotti; Francesco Fanfani; Alfredo Ercoli; Vito Chiantera; Giovanni Scambia; Giuseppe Vizzielli
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.